Drug Stores Market Research Reports & Industry Analysis
The majority of drug store sales are due to the number of prescriptions they fill, as prescriptions are the initial cause of customer traffic in the store. The remaining profit they generate comes from the sale of the “front-end” items. The volume of “front-end” merchandise in drug stores is growing due to drug store companies expanding the selection in order to increase revenue.
The demand for drug stores is dependent upon the need for medical prescriptions, the aging population, and new advances and innovations in medical care. Competition exists between different companies involved in manufacturing of the goods found in drug stores, and also between alternative retailers that offer similar services. Large drug store companies have advantages in purchasing for their locations, and as they are already established in the market they have access to an extensive consumer base. Smaller drug store companies strive to achieve effective and creative advertising strategies to garner more consumer traffic, and also focus on operating out of convenient locations. Independent companies primarily rely on their accessibility to medical insurance businesses to generate a profit.
Drug Stores Industry Research & Market Reports
-
OTC Braces and Supports
... reach US$1.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Lower Extremity Braces & Supports, one of the segments analyzed in the report, is expected to record a 4.9% ... Read More
-
Compounding Pharmacy
... at a CAGR of 4.5% over the analysis period 2023-2030. Oral Compounded Medications, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$8.6 Billion by the end ... Read More
-
Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, Sublingual, and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034 Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, ... Read More
-
China Diabetes Device Market Forecast Report by Types (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies) and Company Analysis 2024-2032
... Size The China Diabetes Device market is expected to reach US$ 6.22 Billion in 2023 to US$ 12.74 Billion by 2032, with a CAGR of 8.29 % from 2024 to 2032. Recent decades have seen ... Read More
-
France Diabetes Device Market Forecast Report by Types (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies) and Company Analysis 2024-2032
... Size The France Diabetes Device market is expected to reach US$ 946.9 Million in 2023 to US$ 1,784.6 Billion by 2032, with a CAGR of 7.30 % from 2024 to 2032. The market for diabetes ... Read More
-
Global Digestive Remedies Market: Analysis By Type (Antacids, Laxatives, Diarrheal Remedies, Proton Pump Inhibitors (PPIs), Digestive Enzymes, Motion Sickness, and Others), By Formulation (Capsules, Tablets, Powder, and Others), By Distribution Channel (Pharmacies & Drugstores, Online Providers, and Others), By End User (Adults, and Pediatrics), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... Providers, and Others), By End User (Adults, and Pediatrics), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2029 Base Year 2023 ... Read More
-
Gluten-free Products Market by Type (Bakery Products, Snacks & RTE Products, Pizzas & Pastas, Condiments & Dressings), Form, Distribution Channel (Conventional Stores, Specialty Stores, and Drugstores & Pharmacies), Source - Global Forecast to 2029
... global gluten-free products market size is estimated to be valued at USD 7.70 billion in 2024 and is projected to reach USD 11.48 billion by 2029 at a CAGR of 8.3%. The increasing prevalence of ... Read More
-
Europe Artifical Tears Market: Market Size, Forecast, Insights, and Competitive Landscape
... report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the Europe artificial tears market by segmenting the market based on ... Read More
-
Australia and New Zealand Nutritional Supplements Market (Powder, Tablets, Capsules, Liquid, Soft Gels, Others); By Product Type (Sports Nutrition, Dietary Supplements, Fat Burner, Functional Food, Others); By Age Group (Kids, Adults, Geriatric); By Distribution Channel (Supermarkets/Hypermarkets, Specialty Stores, Pharmacies, E-commerce, Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... (Supermarkets/Hypermarkets, Specialty Stores, Pharmacies, E-commerce, Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 Australia & New Zealand Nutritional Supplements Market Booming to Surpass USD 9.7 Billion by 2030 Australia & New Zealand Nutritional Supplements Market ... Read More
-
Global Benzodiazepine Drugs Market Size study, by Drug Type (Alprazolam, Clonazepam, Diazepam, Lorazepam, Others), by Application (Anxiety, Insomnia, Alcohol Withdrawal, Seizures, Others), by Time of Action (Ultra-short Acting, Short Acting, Long Acting), by End-user (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2022-2032
... Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2022-2032 The Global Benzodiazepine Drugs Market is valued at approximately USD 2.2 billion in 2023 and is anticipated to grow with a steady growth rate of 3.5% ... Read More
-
Global Consumer Healthcare Market Size Study, by Product (OTC Pharmaceuticals, Dietary Supplements), by Distribution Channel (Offline, Online), and Regional Forecasts 2022-2032
... is anticipated to expand at a robust CAGR of 6.78% over the forecast period from 2024 to 2032. Consumer healthcare plays a pivotal role in empowering individuals to manage their health and well-being through accessible ... Read More
-
Global High Volume Dispensing Systems Market 2024-2028
... the high volume dispensing systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Global Prescription Delivery Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... delivery services include proper storage of drugs, if the drugs require cold storage or refrigeration then the delivery should happen in correct temperature during transit. Prescription delivery services make sure that the pharmacy is responsible ... Read More
-
C-X-C Chemokine Receptor 4 (CXCR4) Antagonists Global Market Report 2024 Including: 1) By Type: BL-8040; GMI-1359; Plerixafor (AMD3100); Balixafortide (POL6326); USL311; Burixafor (GPC-100) 2) By Route Of Administration: Oral; Injectable 3) By Product Pipeline: Approved; Clinical Trials; Pre-Clinical 4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies Covering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers Squibb Company; AstraZeneca plc
... Pre-Clinical4) By Application: Cancer; Human Immunodeficiency Virus (HIV); Chronic Inflammatory Disease; Stem Cell Mobilization; Immune And Autoimmune Diseases5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Pfizer Inc.; F-Hoffmann La Roche Ltd.; Sanofi; Bristol-Myers ... Read More
-
Duodenal Ulcer Treatment Global Market Report 2024 Including: 1) By Type: Antibiotics; Proton Pump Inhibitors; Antacids; Potassium-Competitive Acid Blockers; H2-Antagonist; Ulcer Protective Drugs; Surgery 2) By Application: Adult; Elderly 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy Covering: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Sanofi S.A; Bristol-Myers Squibb
... Online PharmacyCovering: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Sanofi S.A; Bristol-Myers Squibb Duodenal Ulcer Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical ... Read More
-
Contraceptive Devices Global Market Report 2024 Including: 1) By Product Type: Male Contraceptive Devices; Female Contraceptive Devices; Female Condoms, Diaphragms And Sponges; Vaginal Rings; Intrauterine Devices; Sub-Dermal Implants 2) By Technology: Hormonal Contraceptives; Barrier Contraceptives 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Clinics; Online Channels; Public Channel And Non-Governmental Organization (NGO) Covering: Pfizer Inc.; Johnson & Johnson Services Inc.; Bayer AG; Boehringer Ingelheim International GmbH.; Teva Pharmaceutical Industries Ltd.
... Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Clinics; Online Channels; Public Channel And Non-Governmental Organization (NGO)Covering: Pfizer Inc.; Johnson & Johnson Services Inc.; Bayer AG; Boehringer Ingelheim International GmbH.; Teva Pharmaceutical Industries Ltd. Contraceptive Devices Global ... Read More
-
Empagliflozin, Dapagliflozin And Canagliflozin Global Market Report 2024 Including: 1) By Type: Empagliflozin; Dapagliflozin; Canagliflozin 2) By Application: Application I; Application II; Application III; Application IV 3) By Channel: Hospital; Pharmacy Covering: Pfizer Inc.; Merck & Co. Inc.; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca PLC
... Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca PLC Empagliflozin, Dapagliflozin And Canagliflozin Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the ... Read More
-
Dysphagia Supplement Global Market Report 2024 Including: 1) By Type: Powder Thickener; Ready To Drink Thickened Beverages; Instant Food; Oral Nutritional Supplements 2) By Indication: Oropharyngeal Dysphagia; Esophageal Dysphagia 3) By Applications: Hospitals; Nursing Homes; Retail Pharmacies; Drug Stores; Supermarkets Covering: Nestlé S.A. ; Abbott Laboratories; Fresenius SE & Co. KGaA; Groupe Lactalis S.A.; Danone S.A.
... Drug Stores; SupermarketsCovering: Nestlé S.A. ; Abbott Laboratories; Fresenius SE & Co. KGaA; Groupe Lactalis S.A.; Danone S.A. Dysphagia Supplement Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Drug Stores
... CVS Health, Rite Aid, and Walgreens (all based in the US), along with AS Watson Group (Hong Kong), Boots (UK), China Nepstar (China), Dm-Drogerie Markt and Rossmann (both based in Germany), Jean Coutu and Shoppers ... Read More
-
South & Central America Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The South & Central America epilepsy market was valued at US$ 593.56 million ... Read More
-
North America Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The North America epilepsy market was valued at US$ 2,577.10 million in 2022 and is ... Read More
-
Europe Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The Europe epilepsy market was valued at US$ 1,940.58 million in 2022 and is expected to ... Read More
-
Middle East & Africa Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The Middle East & Africa epilepsy market was valued at US$ 456.34 million ... Read More
-
Asia Pacific Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The Asia Pacific epilepsy market was valued at US$ 2,200.92 million in 2022 and is ... Read More
-
Pharmacy Benefit Management in the US - Industry Market Research Report
... the US healthcare system. They help process prescription claims, negotiate rebates, develop drug formularies and review drug usage rates. Historically, PBMs have served as third-party administrators of prescription drug programs. The role of PBMs has ... Read More
Research Assistance
